Eurax and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Eurax (crotamiton), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Urso 250, and have Hepatic neoplasm malignant.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Eurax. It is created by eHealthMe based on reports of 863 people who have side effects when taking Eurax from the FDA, and is updated regularly.

What is Eurax?

Eurax has active ingredients of crotamiton. eHealthMe is studying from 864 Eurax users. Check the latest studies of Eurax.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,962 drugs and 1,976 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

863 people reported to have side effects when taking Eurax.
Among them, 13 people (1.51%) have Dermatitis - atopic.

Among these 13 people:

How long have people been on Eurax when they have Dermatitis - atopic? *

What is the gender of people who have Dermatitis - atopic when taking Eurax? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Dermatitis - atopic when taking Eurax? *

What are other drugs people take besides Eurax? *

What are other side effects people have besides Dermatitis - atopic? *

Diarrhea: 10 people, 76.92%
Anaemia (lack of blood): 7 people, 53.85%
Back Pain: 6 people, 46.15%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 5 people, 38.46%
Dementia (madness): 5 people, 38.46%
Ascites (accumulation of fluid in the abdominal cavity): 5 people, 38.46%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 5 people, 38.46%
Peritonitis Bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial): 5 people, 38.46%
Chills (felling of cold): 4 people, 30.77%
Interstitial Lung Disease: 4 people, 30.77%

What are the existing conditions these people have? *

Hepatic Neoplasm Malignant (liver cancer): 5 people, 38.46%
Insomnia (sleeplessness): 3 people, 23.08%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 3 people, 23.08%
Constipation: 2 people, 15.38%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 2 people, 15.38%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 15.38%
Gastritis (inflammation of stomach): 2 people, 15.38%
Dyspnea (difficult or laboured breathing): 2 people, 15.38%
Drug Eruption (adverse drug reaction of the skin): 2 people, 15.38%
Diarrhea: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Eurax and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eurax:

Eurax (864 reports)

Browse all side effects of Eurax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,962 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,976 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on crotamiton (the active ingredients of Eurax) and Eurax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.